Quantcast

Latest The City of London Migraine Clinic Stories

2009-02-18 08:30:00

SAN DIEGO, Feb. 18 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced that the U.S. Food & Drug Administration (FDA) has provided a target date of July 15, 2009 for completion of its review of the NDA for Sumavel DosePro (sumatriptan injection) needle-free delivery system. Zogenix is seeking marketing approval of Sumavel DosePro for the acute treatment of migraine attacks with or without aura, and the acute treatment of cluster headache...

2009-02-17 10:28:15

New research looks at whether a gene variant may affect the link between migraine and stroke or heart attacks. The study is published in the February 17, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.The study involved 25,000 women who answered a questionnaire about their history of migraines and migraines with aura. Aura is usually described as visual disturbances, such as flashing lights or geometric patterns. The women were...

2009-02-16 14:51:07

New research links larger waistlines to an increased risk of migraine headaches.  The findings will be released in May at the American Academy of Neurology's Annual meeting. In the study, researchers questioned over twenty thousand people between the ages of 20 and 55 about the severity of their headaches. They discovered age, gender and the way body fat is distributed affected the risk of migraine. "These results, while still in the early stages, suggest that losing weight in the...

72d435031358e640a1cc6c4b95f9d2691
2009-02-13 09:03:36

Overweight people who are between the ages of 20 and 55 may have a higher risk of experiencing migraine headaches, according to a study released today that will be presented at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 to May 2, 2009. For the study, abdominal obesity was measured by waist circumference or the total size around the waist. Total body obesity was also measured. This was calculated using the body mass index, a measurement related to weight and...

2009-02-02 15:35:40

 A new study published in Value in Health reviews the economic burden of migraine in the U.S. and recent clinical findings of the health risks of this neurological condition. This study traces the history of economic articles published on migraine using the PubMed MEDLINE database and archival searches of relevant articles to identify possible health risks associated with migraines that warrant further study.Migraine affects millions of individuals worldwide. Sufferers experience...

78e88858201435a3023a185d36bd6fc71
2009-01-31 13:53:01

A new survey suggests, that despite the pervasiveness of migraine and other headache disorders in the U.S., most individuals suffering a severe headache steer clear of emergency departments. "The patients most likely to use the ED for management of headache were those who used the ED for management of everything," Dr. Benjamin W. Friedman, of Albert Einstein College of Medicine and Montefiore Medical Center in Bronx, New York, told Reuters Health. Friedman and colleagues report in the journal...

2009-01-26 07:00:00

MOUNTAIN VIEW, Calif., Jan. 26 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that it has completed patient enrollment in the efficacy portion of its initial Phase 3 clinical trial evaluating MAP0004, the company's novel, orally inhaled product candidate for the acute treatment of migraine. "In our Phase 2 clinical trial, MAP0004 demonstrated the potential to be both fast acting and long-lasting, providing pain relief in as fast as ten minutes with...

2008-10-27 12:00:30

Minster Pharmaceuticals, a drug development company, has announced positive results from its Phase II trial in Denmark of tonabersat in the prevention of migraine with aura. According to the company, the median number of aura attacks was reduced by 68% (p=0.01) in patients receiving tonabersat when compared with placebo. This result in the primary endpoint of the study is both clinically and statistically highly significant. A further primary endpoint showed a reduction in the number of...

2008-10-24 15:00:24

ESSEX, United Kingdom, Oct. 24 /PRNewswire-FirstCall/ -- Minster Pharmaceuticals plc (AIM: MPM), the drug development company specializing in neurological and psychiatric disorders, is pleased to announce positive results from its Phase II trial in Denmark of tonabersat in the prevention of migraine with aura. The median number of aura attacks was reduced by 68% (p=0.01) in patients receiving tonabersat when compared with placebo. This result in the primary endpoint of the study is both...

2008-09-12 12:00:35

Allergan, a multi-specialty healthcare company, has completed a top-line analysis of its two Phase III clinical trials exploring the use of Botox for the prophylactic treatment of headache in adults suffering from chronic migraine. In the two Phase III clinical trials, patients were randomly assigned to treatment with Botox or placebo injections every 12 weeks. The primary analysis was performed at week 24 following two treatment cycles. The two major efficacy measures evaluated in the...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related